KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Assets Average (2016 - 2025)

Historic Assets Average for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to $3.0 billion.

  • Ionis Pharmaceuticals' Assets Average rose 426.17% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 426.17%. This contributed to the annual value of $3.0 billion for FY2024, which is 850.48% up from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Assets Average stood at $3.0 billion for Q3 2025, which was up 426.17% from $2.9 billion recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Assets Average peaked at $3.0 billion during Q4 2024, and registered a low of $2.3 billion during Q1 2021.
  • Moreover, its 5-year median value for Assets Average was $2.7 billion (2024), whereas its average is $2.7 billion.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Assets Average crashed by 2665.58% in 2021, and later surged by 2105.32% in 2023.
  • Ionis Pharmaceuticals' Assets Average (Quarter) stood at $2.5 billion in 2021, then fell by 1.41% to $2.5 billion in 2022, then increased by 19.54% to $3.0 billion in 2023, then increased by 2.71% to $3.0 billion in 2024, then dropped by 1.09% to $3.0 billion in 2025.
  • Its Assets Average stands at $3.0 billion for Q3 2025, versus $2.9 billion for Q2 2025 and $2.9 billion for Q1 2025.